Llorente/Sandvig publish potential biomarkers for prostate cancer

Ghiasvand R (2026)
High-Risk Stage II Melanoma: AJCC Staging anomaly or understaging dilemma?
Br J Dermatol (in press)
DOI 10.1093/bjd/ljaf523, PubMed 41483011

Unal B, Saatcioglu F (2025)
Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression
Biomark Res, 13 (1), 156
DOI 10.1186/s40364-025-00813-y, PubMed 41372991

Pinto R, Sjurgard IV, Pharo H, Mala T, Vedeld HM, Lind GE (2025)
Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy
Oncogene (in press)
DOI 10.1038/s41388-025-03650-3, PubMed 41361079

Van der Pol H, Kringelbach T, Martin Agudo M, Bratseth Stav G, Fagereng GL, Fiocco M, Sørum Falk R, Homer V, Haj Mohammad S, Timmer H, Verlingue L, Helland Å, Rohrberg K, Lassen U, Halford S, Jalkanen K, Juslin T, Krebs MG, Oliveira J, Baltruskeviciene E, Ojamaa K, Taskén K, Gelderblom H (2026)
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project
Acta Oncol, 65, 1-8
DOI 10.2340/1651-226X.2026.44889, PubMed 41496458

Wang X, Nguyen J, Nader K, Miihkinen M, Wall P, Singhal A, Bedard PL, Ideker T, Aittokallio T, Haibe-Kains B (2026)
Discovery of predictive biomarkers for cancer therapy through computational approaches
Nat Rev Clin Oncol (in press)
DOI 10.1038/s41571-025-01109-8, PubMed 41495240

Kanetsky PA, Almstrup K, Cherlin S, Cortessis VK, Ferlin A, Gietema JA, González-Neira A, Grotmol T, Hamilton RJ, Haugen TB, Kiemeney LA, Kim J, Krausz C, Lessel D, Lothe RA, Nead KT, Nsengimana J, Poynter JN, Rajpert-DeMeyts E, Richiardi L, Schwartz SM, Skotheim RI, Stewart DR, Turnbull C, Wiklund F et al. (2026)
The Testicular Cancer Consortium (TECAC): Filling Knowledge Gaps in the Genetic Etiology of Testicular Germ Cell Tumors
Andrology, e70168 (in press)
DOI 10.1111/andr.70168, PubMed 41486674